Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Post-adjuvant chemo for ctDNA+ CRC studied in ALTAIR trial: stage 0-IV, detects MRD post-surgery. Early intervention impact unknown. PMID:42260101, Nat Med 2026, @NatureMedicine #Medsky #Pharmsky…
Read the full article3d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Medicinal plants used to treat infectious diseases in French Polynesia: an ethnobotanical survey and antibacterial evaluation
archimer.ifremer.fr·just now
A standardized method to monitor marine litter in submarine canyons: implementation in Atlantic and Mediterranean reef ecosystems
archimer.ifremer.fr·just now
Unveiling the subchronic effects of PFAS mixtures in blue mussels (Mytilus spp.): An integrative assessment from molecular to physiological levels
archimer.ifremer.fr·just now
Microplastics in the marine environment: development of a new citizen science tool
archimer.ifremer.fr·just now
Global sensitivity analysis of a complex marine ecosystem model: Advancing the understanding of ecosystem functioning
archimer.ifremer.fr·just now
Comments
Sign in to join the conversation.
No comments yet. Be the first.